Global Biopharmaceuticals Market Size, Status and Forecast 2020-2026

Global Biopharmaceuticals Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biopharmaceuticals Revenue
1.4 Market Analysis by Type
1.4.1 Global Biopharmaceuticals Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Interferon
1.4.4 Colony-Stimulating Factor
1.4.5 Erythropoietin
1.4.6 Insulin
1.4.7 Vaccines
1.4.8 Growth Hormones
1.4.9 Others
1.5 Market by Application
1.5.1 Global Biopharmaceuticals Market Share by Application: 2020 VS 2026
1.5.2 Tumor
1.5.3 Diabetes
1.5.4 Cardiovascular
1.5.5 Hemophilia
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Biopharmaceuticals Industry Impact
1.6.1 How the Covid-19 is Affecting the Biopharmaceuticals Industry
1.6.1.1 Biopharmaceuticals Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biopharmaceuticals Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biopharmaceuticals Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Biopharmaceuticals Market Perspective (2015-2026)
2.2 Biopharmaceuticals Growth Trends by Regions
2.2.1 Biopharmaceuticals Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biopharmaceuticals Historic Market Share by Regions (2015-2020)
2.2.3 Biopharmaceuticals Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Biopharmaceuticals Market Growth Strategy
2.3.6 Primary Interviews with Key Biopharmaceuticals Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceuticals Players by Market Size
3.1.1 Global Top Biopharmaceuticals Players by Revenue (2015-2020)
3.1.2 Global Biopharmaceuticals Revenue Market Share by Players (2015-2020)
3.1.3 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biopharmaceuticals Market Concentration Ratio
3.2.1 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceuticals Revenue in 2019
3.3 Biopharmaceuticals Key Players Head office and Area Served
3.4 Key Players Biopharmaceuticals Product Solution and Service
3.5 Date of Enter into Biopharmaceuticals Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Biopharmaceuticals Historic Market Size by Type (2015-2020)
4.2 Global Biopharmaceuticals Forecasted Market Size by Type (2021-2026)
5 Biopharmaceuticals Breakdown Data by Application (2015-2026)
5.1 Global Biopharmaceuticals Market Size by Application (2015-2020)
5.2 Global Biopharmaceuticals Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biopharmaceuticals Market Size (2015-2020)
6.2 Biopharmaceuticals Key Players in North America (2019-2020)
6.3 North America Biopharmaceuticals Market Size by Type (2015-2020)
6.4 North America Biopharmaceuticals Market Size by Application (2015-2020)
7 Europe
7.1 Europe Biopharmaceuticals Market Size (2015-2020)
7.2 Biopharmaceuticals Key Players in Europe (2019-2020)
7.3 Europe Biopharmaceuticals Market Size by Type (2015-2020)
7.4 Europe Biopharmaceuticals Market Size by Application (2015-2020)
8 China
8.1 China Biopharmaceuticals Market Size (2015-2020)
8.2 Biopharmaceuticals Key Players in China (2019-2020)
8.3 China Biopharmaceuticals Market Size by Type (2015-2020)
8.4 China Biopharmaceuticals Market Size by Application (2015-2020)
9 Japan
9.1 Japan Biopharmaceuticals Market Size (2015-2020)
9.2 Biopharmaceuticals Key Players in Japan (2019-2020)
9.3 Japan Biopharmaceuticals Market Size by Type (2015-2020)
9.4 Japan Biopharmaceuticals Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Biopharmaceuticals Market Size (2015-2020)
10.2 Biopharmaceuticals Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biopharmaceuticals Market Size by Type (2015-2020)
10.4 Southeast Asia Biopharmaceuticals Market Size by Application (2015-2020)
11 India
11.1 India Biopharmaceuticals Market Size (2015-2020)
11.2 Biopharmaceuticals Key Players in India (2019-2020)
11.3 India Biopharmaceuticals Market Size by Type (2015-2020)
11.4 India Biopharmaceuticals Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Biopharmaceuticals Market Size (2015-2020)
12.2 Biopharmaceuticals Key Players in Central & South America (2019-2020)
12.3 Central & South America Biopharmaceuticals Market Size by Type (2015-2020)
12.4 Central & South America Biopharmaceuticals Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview and Its Total Revenue
13.1.3 Roche Biopharmaceuticals Introduction
13.1.4 Roche Revenue in Biopharmaceuticals Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview and Its Total Revenue
13.2.3 Amgen Biopharmaceuticals Introduction
13.2.4 Amgen Revenue in Biopharmaceuticals Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 AbbVie
13.3.1 AbbVie Company Details
13.3.2 AbbVie Business Overview and Its Total Revenue
13.3.3 AbbVie Biopharmaceuticals Introduction
13.3.4 AbbVie Revenue in Biopharmaceuticals Business (2015-2020)
13.3.5 AbbVie Recent Development
13.4 Sanofi-Aventis
13.4.1 Sanofi-Aventis Company Details
13.4.2 Sanofi-Aventis Business Overview and Its Total Revenue
13.4.3 Sanofi-Aventis Biopharmaceuticals Introduction
13.4.4 Sanofi-Aventis Revenue in Biopharmaceuticals Business (2015-2020)
13.4.5 Sanofi-Aventis Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview and Its Total Revenue
13.5.3 Johnson & Johnson Biopharmaceuticals Introduction
13.5.4 Johnson & Johnson Revenue in Biopharmaceuticals Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview and Its Total Revenue
13.6.3 Pfizer Biopharmaceuticals Introduction
13.6.4 Pfizer Revenue in Biopharmaceuticals Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Details
13.7.2 Novo Nordisk Business Overview and Its Total Revenue
13.7.3 Novo Nordisk Biopharmaceuticals Introduction
13.7.4 Novo Nordisk Revenue in Biopharmaceuticals Business (2015-2020)
13.7.5 Novo Nordisk Recent Development
13.8 Eli Lilly
13.8.1 Eli Lilly Company Details
13.8.2 Eli Lilly Business Overview and Its Total Revenue
13.8.3 Eli Lilly Biopharmaceuticals Introduction
13.8.4 Eli Lilly Revenue in Biopharmaceuticals Business (2015-2020)
13.8.5 Eli Lilly Recent Development
13.9 Novartis
13.9.1 Novartis Company Details
13.9.2 Novartis Business Overview and Its Total Revenue
13.9.3 Novartis Biopharmaceuticals Introduction
13.9.4 Novartis Revenue in Biopharmaceuticals Business (2015-2020)
13.9.5 Novartis Recent Development
13.10 Merck
13.10.1 Merck Company Details
13.10.2 Merck Business Overview and Its Total Revenue
13.10.3 Merck Biopharmaceuticals Introduction
13.10.4 Merck Revenue in Biopharmaceuticals Business (2015-2020)
13.10.5 Merck Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Biopharmaceuticals Key Market Segments
Table 2. Key Players Covered: Ranking by Biopharmaceuticals Revenue
Table 3. Ranking of Global Top Biopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Interferon
Table 7. Key Players of Colony-Stimulating Factor
Table 8. Key Players of Erythropoietin
Table 9. Key Players of Insulin
Table 10. Key Players of Vaccines
Table 11. Key Players of Growth Hormones
Table 12. Key Players of Others
Table 13. COVID-19 Impact Global Market: (Four Biopharmaceuticals Market Size Forecast Scenarios)
Table 14. Opportunities and Trends for Biopharmaceuticals Players in the COVID-19 Landscape
Table 15. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 16. Key Regions/Countries Measures against Covid-19 Impact
Table 17. Proposal for Biopharmaceuticals Players to Combat Covid-19 Impact
Table 18. Global Biopharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 19. Global Biopharmaceuticals Market Size by Regions (US$ Million): 2020 VS 2026
Table 20. Global Biopharmaceuticals Market Size by Regions (2015-2020) (US$ Million)
Table 21. Global Biopharmaceuticals Market Share by Regions (2015-2020)
Table 22. Global Biopharmaceuticals Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 23. Global Biopharmaceuticals Market Share by Regions (2021-2026)
Table 24. Market Top Trends
Table 25. Key Drivers: Impact Analysis
Table 26. Key Challenges
Table 27. Biopharmaceuticals Market Growth Strategy
Table 28. Main Points Interviewed from Key Biopharmaceuticals Players
Table 29. Global Biopharmaceuticals Revenue by Players (2015-2020) (Million US$)
Table 30. Global Biopharmaceuticals Market Share by Players (2015-2020)
Table 31. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2019)
Table 32. Global Biopharmaceuticals by Players Market Concentration Ratio (CR5 and HHI)
Table 33. Key Players Headquarters and Area Served
Table 34. Key Players Biopharmaceuticals Product Solution and Service
Table 35. Date of Enter into Biopharmaceuticals Market
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 38. Global Biopharmaceuticals Market Size Share by Type (2015-2020)
Table 39. Global Biopharmaceuticals Revenue Market Share by Type (2021-2026)
Table 40. Global Biopharmaceuticals Market Size Share by Application (2015-2020)
Table 41. Global Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 42. Global Biopharmaceuticals Market Size Share by Application (2021-2026)
Table 43. North America Key Players Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 44. North America Key Players Biopharmaceuticals Market Share (2019-2020)
Table 45. North America Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 46. North America Biopharmaceuticals Market Share by Type (2015-2020)
Table 47. North America Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 48. North America Biopharmaceuticals Market Share by Application (2015-2020)
Table 49. Europe Key Players Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 50. Europe Key Players Biopharmaceuticals Market Share (2019-2020)
Table 51. Europe Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 52. Europe Biopharmaceuticals Market Share by Type (2015-2020)
Table 53. Europe Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 54. Europe Biopharmaceuticals Market Share by Application (2015-2020)
Table 55. China Key Players Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 56. China Key Players Biopharmaceuticals Market Share (2019-2020)
Table 57. China Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 58. China Biopharmaceuticals Market Share by Type (2015-2020)
Table 59. China Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 60. China Biopharmaceuticals Market Share by Application (2015-2020)
Table 61. Japan Key Players Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 62. Japan Key Players Biopharmaceuticals Market Share (2019-2020)
Table 63. Japan Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 64. Japan Biopharmaceuticals Market Share by Type (2015-2020)
Table 65. Japan Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 66. Japan Biopharmaceuticals Market Share by Application (2015-2020)
Table 67. Southeast Asia Key Players Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 68. Southeast Asia Key Players Biopharmaceuticals Market Share (2019-2020)
Table 69. Southeast Asia Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 70. Southeast Asia Biopharmaceuticals Market Share by Type (2015-2020)
Table 71. Southeast Asia Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 72. Southeast Asia Biopharmaceuticals Market Share by Application (2015-2020)
Table 73. India Key Players Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 74. India Key Players Biopharmaceuticals Market Share (2019-2020)
Table 75. India Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 76. India Biopharmaceuticals Market Share by Type (2015-2020)
Table 77. India Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 78. India Biopharmaceuticals Market Share by Application (2015-2020)
Table 79. Central & South America Key Players Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 80. Central & South America Key Players Biopharmaceuticals Market Share (2019-2020)
Table 81. Central & South America Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 82. Central & South America Biopharmaceuticals Market Share by Type (2015-2020)
Table 83. Central & South America Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 84. Central & South America Biopharmaceuticals Market Share by Application (2015-2020)
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Product
Table 88. Roche Revenue in Biopharmaceuticals Business (2015-2020) (Million US$)
Table 89. Roche Recent Development
Table 90. Amgen Company Details
Table 91. Amgen Business Overview
Table 92. Amgen Product
Table 93. Amgen Revenue in Biopharmaceuticals Business (2015-2020) (Million US$)
Table 94. Amgen Recent Development
Table 95. AbbVie Company Details
Table 96. AbbVie Business Overview
Table 97. AbbVie Product
Table 98. AbbVie Revenue in Biopharmaceuticals Business (2015-2020) (Million US$)
Table 99. AbbVie Recent Development
Table 100. Sanofi-Aventis Company Details
Table 101. Sanofi-Aventis Business Overview
Table 102. Sanofi-Aventis Product
Table 103. Sanofi-Aventis Revenue in Biopharmaceuticals Business (2015-2020) (Million US$)
Table 104. Sanofi-Aventis Recent Development
Table 105. Johnson & Johnson Company Details
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Product
Table 108. Johnson & Johnson Revenue in Biopharmaceuticals Business (2015-2020) (Million US$)
Table 109. Johnson & Johnson Recent Development
Table 110. Pfizer Company Details
Table 111. Pfizer Business Overview
Table 112. Pfizer Product
Table 113. Pfizer Revenue in Biopharmaceuticals Business (2015-2020) (Million US$)
Table 114. Pfizer Recent Development
Table 115. Novo Nordisk Company Details
Table 116. Novo Nordisk Business Overview
Table 117. Novo Nordisk Product
Table 118. Novo Nordisk Revenue in Biopharmaceuticals Business (2015-2020) (Million US$)
Table 119. Novo Nordisk Recent Development
Table 120. Eli Lilly Business Overview
Table 121. Eli Lilly Product
Table 122. Eli Lilly Company Details
Table 123. Eli Lilly Revenue in Biopharmaceuticals Business (2015-2020) (Million US$)
Table 124. Eli Lilly Recent Development
Table 125. Novartis Company Details
Table 126. Novartis Business Overview
Table 127. Novartis Product
Table 128. Novartis Revenue in Biopharmaceuticals Business (2015-2020) (Million US$)
Table 129. Novartis Recent Development
Table 130. Merck Company Details
Table 131. Merck Business Overview
Table 132. Merck Product
Table 133. Merck Revenue in Biopharmaceuticals Business (2015-2020) (Million US$)
Table 134. Merck Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceuticals Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Interferon Features
Figure 4. Colony-Stimulating Factor Features
Figure 5. Erythropoietin Features
Figure 6. Insulin Features
Figure 7. Vaccines Features
Figure 8. Growth Hormones Features
Figure 9. Others Features
Figure 10. Global Biopharmaceuticals Market Share by Application: 2020 VS 2026
Figure 11. Tumor Case Studies
Figure 12. Diabetes Case Studies
Figure 13. Cardiovascular Case Studies
Figure 14. Hemophilia Case Studies
Figure 15. Others Case Studies
Figure 16. Biopharmaceuticals Report Years Considered
Figure 17. Global Biopharmaceuticals Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Biopharmaceuticals Market Share by Regions: 2020 VS 2026
Figure 19. Global Biopharmaceuticals Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Biopharmaceuticals Market Share by Players in 2019
Figure 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Biopharmaceuticals Revenue in 2019
Figure 24. North America Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Roche Revenue Growth Rate in Biopharmaceuticals Business (2015-2020)
Figure 33. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Amgen Revenue Growth Rate in Biopharmaceuticals Business (2015-2020)
Figure 35. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AbbVie Revenue Growth Rate in Biopharmaceuticals Business (2015-2020)
Figure 37. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Sanofi-Aventis Revenue Growth Rate in Biopharmaceuticals Business (2015-2020)
Figure 39. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Johnson & Johnson Revenue Growth Rate in Biopharmaceuticals Business (2015-2020)
Figure 41. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Pfizer Revenue Growth Rate in Biopharmaceuticals Business (2015-2020)
Figure 43. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Novo Nordisk Revenue Growth Rate in Biopharmaceuticals Business (2015-2020)
Figure 45. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Eli Lilly Revenue Growth Rate in Biopharmaceuticals Business (2015-2020)
Figure 47. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Novartis Revenue Growth Rate in Biopharmaceuticals Business (2015-2020)
Figure 49. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Merck Revenue Growth Rate in Biopharmaceuticals Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biopharmaceuticals Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Biopharmaceuticals market size was valued at US$ 31700 million in 2023. With growing demand in downstream market, the Biopharmaceuticals is forecast to a readjusted size of US$ 55380 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Biopharmaceuticals market. Biopharmaceuticals are expected to show stable growth in the future market. However, product di......

Global Bio-Pharma Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Bio-Pharma market: According to our latest research, the global Bio-Pharma market looks promising in the next 5 years. As of 2022, the global Bio-Pharma market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Bio-Pharma market, with a systematical de......

Global Bio-pharma Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 91

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bio-pharma market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Pfizer - F. Hoffmann-La Roche AG - Johnson & Johnson Services - Sanofi, Amgen - AbbVie - Merck & Co., Inc - Biogen Idec - Bayer AG - E......

Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), & End User - Global Forecast to 2028

Published: 24-Nov-2023        Price: US 4950 Onwards        Pages: 273

“Rising demand for biopharmaceuticals and growing adoption among CDMOs and CMOs are driving the growth of the continuous bioprocessing market.” The global continuous bioprocessing market is projected to reach USD 599 million by 2028 from USD 218 million in 2023, at a CAGR of 22.4% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing adoption of continuous bioprocessing among CDMOs and CMOs. Continuous b......

Global Biopharmaceuticals Professional Survey Report 2023, Forecast to 2028

Published: 20-Nov-2023        Price: US 3280 Onwards        Pages: 139

A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......

Global Biopharmaceuticals Market Research Report 2023, Forecast to 2028

Published: 20-Nov-2023        Price: US 2680 Onwards        Pages: 160

A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......

2023-2031 Report on Global Biopharmaceuticals Market by Player, Region, Type, Application and Sales Channel

Published: 18-Sep-2023        Price: US 2500 Onwards        Pages: 85

This report studies the Biopharmaceuticals market, covering market size for segment by type (Monoclonal Antibodies, Interferon, etc.), by application (Tumor, Diabetes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, Abbvie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Biopharmaceutic......

Global Bio-pharma Market Insights, Forecast to 2029

Published: 10-Aug-2023        Price: US 4900 Onwards        Pages: 108

The global Bio-pharma market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of......

Biopharmaceuticals Markets in China

Published: 24-Jul-2023        Price: US 4000 Onwards        Pages: 233

China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs